Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

v3.24.3
Warrants (Tables)
9 Months Ended
Sep. 30, 2024
Warrants  
Schedule of Warrants Outstanding and Exercisable

The Company’s outstanding and exercisable warrants as of September 30, 2024 are presented below:

 

   

Number of

Warrants

   

Weighted

Average

Exercise Price

 
Warrants outstanding at December 31, 2023     260,995     $ 82.55  
Issued     530,329       0.90  
Expired     (43,862 )     89.60  
Warrants outstanding at September 30, 2024     747,462       22.98  

 

Warrants
Outstanding
    Exercise Price     Expiration
Date
  10,888     $ 186.00     11/8/2024
  153,334     $ 75.00     5/1/2025
  52,911     $ 60.00     7/17/2025
  70,000     $ 1.88     2/27/2029
  55,000  (1)   $ 1.25     6/29/2029
  405,329  (2)   $ 0.69     9/4/2029
  1,139,705  (3)   $ 0.001      
  1,887,167              

 

All outstanding warrants are classified as equity on the Company’s Condensed Consolidated Balance Sheets.

 

(1) – Dawson James Placement Agent warrants are not exercisable until December 23, 2024.
(2) – Dawson James Placement Agent warrants are not exercisable until March 4, 2025.
(3) – Pre-Funded Warrants from September 5, 2024 financing not yet converted as of November 13, 2024.